Sort
35,931 grants matching “parkinsons”
Assay Development for Substrate and Phosphorylation State Specific JNK Inhibitors
$359,100Philip Lograsso · Scripps Florida · R01 · FY2014 · GM
Assay Development for Substrate and Phosphorylation State Specific JNK Inhibitors
$359,100Philip Lograsso · Scripps Florida · R01 · FY2013 · GM
Structure and Function of Hetero-multimeric Glutamate Receptors
$359,100Hiroyasu Furukawa · Cold Spring Harbor Laboratory · R01 · FY2014 · GM
In vitro neural disease models for high throughput screening
$359,085April M Kloxin · University Of Delaware · P20 · FY2016 · GM
Prefrontal D1 signaling and cognitive symptoms of Parkinson's disease
$359,074Nandakumar Narayanan · University Of Iowa · R01 · FY2017 · NS
Pathogenic Mechanisms of Dynactin p150glued in ALS and Parkinson's Disease
$359,070Huaibin Cai · National Institute On Aging · ZIA · FY2014 · AG
The contribution of the secretory pathway to macroautophagy
$359,054Susan Ferro-Novick · University Of California, San Diego · R01 · FY2017 · GM
Understanding mechanism and therapy of ALS using RNAi
$359,047Zuoshang Xu · Univ Of Massachusetts Med Sch Worcester · R01 · FY2006 · NS
Mechanisms of Retinal Synaptic Plasticity
$359,024Douglas G McMahon · Vanderbilt University · R01 · FY2012 · EY
Navigation with complex odor dynamics: computational principles and neural circuit implementation in mice
$359,000David Henry Gire · University Of Washington · R01 · FY2021 · DC
Diffusion of Substances Through the Brain
$358,987Charles Nicholson · New York University School Of Medicine · R01 · FY2010 · NS
Phosphine-Catalyzed Annulations and their Applications
$358,929Ohyun Kwon · University Of California Los Angeles · R01 · FY2021 · GM
Mechanisms of TNFa Enhancement of Nicotinic Receptor Upregulation
$358,912Lorise C Gahring · University Of Utah · R01 · FY2012 · DA
Mechanisms of TNFa Enhancement of Nicotinic Receptor Upregulation
$358,912Lorise C Gahring · University Of Utah · R01 · FY2011 · DA
Cell Grafts for Parkinson's Disease
$358,900Rush University Medical Center · R01 · FY2001 · NS
Identification of Novel Drugs that Counter Huntington's Disease
$358,897Robert M. Friedlander · Brigham And Women'S Hospital · R01 · FY2007 · NS
Dopamine system plasticity after a partial lesion
$358,875University Of Rochester · R01 · FY2004 · MH
Dopamine system plasticity after a partial lesion
$358,875University Of Rochester · R01 · FY2002 · MH
Dopamine system plasticity after a partial lesion
$358,875University Of Rochester · R01 · FY2005 · MH
Dopamine system plasticity after a partial lesion
$358,875University Of Rochester · R01 · FY2003 · MH
Dieldrin-induced differential gene methylation and parkinsonian toxicity (R01ES031237)
$358,838Alison Bernstein · Rutgers Biomedical And Health Sciences · R01 · FY2024 · ES
Role of inflammation in manganese neurotoxicity: molecular mechanisms
$358,812Nikolay M Filipov · University Of Georgia · R01 · FY2009 · ES
PLASMA CELL-FREE RNA AS NONINVASIVE BIOMARKER FOR PARKINSON'S DISEASE. NEW AWARD.
$358,789Washington University, The · · FY2020 · Defense Health Agency
Yeast as a gateway to conquering protein misfolding diseases.
$358,780Susan W. Liebman · University Of Nevada Reno · R35 · FY2023 · GM
Yeast as a gateway to conquering protein misfolding diseases.
$358,777Susan W. Liebman · University Of Nevada Reno · R35 · FY2024 · GM